Linical Co

Linical Co Capital Expenditures

The Capital Expenditures (CapEx) of Linical Co (2183.T) as of Nov 19, 2026 is -31.65 M JPY. In the previous year, Capital Expenditures (CapEx) was -2.89 M JPY — a change of 996.50% (lower).

Capital Expenditures

-31.65 MJPY

YoY

996.50%

Last updated:

Capital Expenditures (CapEx) of Linical Co is 2026 -31.65 M JPY. Capital Expenditures (CapEx) of Linical Co was 2025 -2.89 M JPY. It decreases by 996.50% lower compared to the previous year.

The Linical Co Capital Expenditures history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Expenditures
Date
Capital Expenditures
Jan 1, 2019
-42.50 M JPY
Jan 1, 2020
-131.81 M JPY
Jan 1, 2021
-68.50 M JPY
Jan 1, 2022
-46.47 M JPY
Jan 1, 2023
-13.23 M JPY
Jan 1, 2024
-29.71 M JPY
Jan 1, 2025
-2.89 M JPY
Jan 1, 2026
-31.65 M JPY
The Linical Co Capital Expenditures history
YEARCapital ExpendituresYoY
-31.65 MJPY+996.50%
-2.89 MJPY-90.28%
-29.71 MJPY+124.47%
-13.23 MJPY-71.52%
-46.47 MJPY-32.16%
-68.50 MJPY-48.03%
-131.81 MJPY+210.14%
-42.50 MJPY-30.41%
-61.08 MJPY+116.67%
-28.19 MJPY-26.58%
-38.40 MJPY+176.82%
-13.87 MJPY+20.83%
-11.48 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Linical Co Stock analysis

What does Linical Co do? Linical Co., Ltd. generates revenue through two distinct business segments, the CRO segment and the Pharmaceutical Sales Support segment. The CRO segment provides contract monitoring, quality management, and consulting services specifically for phase II and phase III in drug development processes. These services are delivered to pharmaceutical companies as part of pharmaceutical contract research projects. The Pharmaceutical Sales Support segment focuses on the downstream market by providing pharmaceutical sales support for medical institutions. The company operates these businesses from its headquarters in Osaka, Osaka-Fu, leveraging its workforce of 759 full-time employees to deliver these specialized services. Linical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Linical Co stock

Capital Expenditures (CapEx) of Linical Co is -31.65 M JPY in 2026.

Capital Expenditures (CapEx) of Linical Co changed from -2.89 M JPY to -31.65 M JPY, representing a 996.50% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Capital Expenditures (CapEx) Linical Co since 2006 – with annual values, charts, and detailed analysis.

Capital expenditures represent investments in long-term assets such as property, equipment, and technology. CapEx is essential for maintaining and growing the business.

Capital Expenditures (CapEx)'s JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Capital Expenditures (CapEx)'s Linical Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Linical Co

All Key Metrics — Linical Co